{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T10:46:40Z","timestamp":1774954000245,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.cca.2023.117559","type":"journal-article","created":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T20:01:08Z","timestamp":1694548868000},"page":"117559","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Exploration and improvement of QuantiFERON-TB assay in patients with indeterminate results in clinical practice: A head-to-head study"],"prefix":"10.1016","volume":"549","author":[{"given":"Linchuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-xiong","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Qin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2023.117559_b0005","series-title":"Global tuberculosis report 2021","year":"2021"},{"issue":"8","key":"10.1016\/j.cca.2023.117559_b0010","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S1473-3099(19)30307-X","article-title":"Global burden of latent multidrug-resistant tuberculosis: trends and estimates based on mathematical modelling","volume":"19","author":"Knight","year":"2019","journal-title":"Lancet Infect. Dis."},{"issue":"9","key":"10.1016\/j.cca.2023.117559_b0015","doi-asserted-by":"crossref","first-page":"e022445","DOI":"10.1136\/bmjopen-2018-022445","article-title":"Screening and prevention for latent tuberculosis in immunosuppressed patients at risk for tuberculosis: a systematic review of clinical practice guidelines","volume":"8","author":"Hasan","year":"2018","journal-title":"BMJ Open"},{"issue":"10","key":"10.1016\/j.cca.2023.117559_b0020","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/resp.13346","article-title":"Latent tuberculosis infection: Opportunities and challenges","volume":"23","author":"Chee","year":"2018","journal-title":"Respirology"},{"issue":"5","key":"10.1016\/j.cca.2023.117559_b0025","doi-asserted-by":"crossref","first-page":"e1002052","DOI":"10.1371\/journal.ppat.1002052","article-title":"A gamma interferon independent mechanism of CD4 T cell mediated control of M. tuberculosis infection in vivo","volume":"7","author":"Gallegos","year":"2011","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.cca.2023.117559_b0030","doi-asserted-by":"crossref","first-page":"270","DOI":"10.4049\/jimmunol.1200061","article-title":"IFN-\u03b3 from CD4 T cells is essential for host survival and enhances CD8 T cell function during Mycobacterium tuberculosis infection","volume":"190","author":"Green","year":"2013","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.cca.2023.117559_b0035","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/imr.12274","article-title":"T cells and adaptive immunity to Mycobacterium tuberculosis in humans","volume":"264","author":"Jasenosky","year":"2015","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.cca.2023.117559_b0040","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.3389\/fimmu.2020.02006","article-title":"Diagnosis for latent tuberculosis infection: New alternatives","volume":"11","author":"Carranza","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cca.2023.117559_b0045","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2019.00208","article-title":"Risk factors for indeterminate interferon-gamma release assay for the diagnosis of tuberculosis in children-A systematic review and meta-analysis","volume":"7","author":"Meier","year":"2019","journal-title":"Front. Pediatr."},{"issue":"2","key":"10.1016\/j.cca.2023.117559_b0050","doi-asserted-by":"crossref","first-page":"180","DOI":"10.5588\/ijtld.13.0276","article-title":"Low prevalence of positive interferon-gamma tests in HIV-positive long-term immigrants in Norway","volume":"18","author":"Pullar","year":"2014","journal-title":"Int. J. Tuberc. Lung Dis."},{"issue":"4","key":"10.1016\/j.cca.2023.117559_b0055","doi-asserted-by":"crossref","first-page":"1602102","DOI":"10.1183\/13993003.02102-2016","article-title":"QuantiFERON test interpretation in patients receiving immunosuppressive agents: an alert","volume":"49","author":"Belliere","year":"2017","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.cca.2023.117559_b0060","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/978-1-4614-6111-1_8","article-title":"Antigen-specific CD8(+) T cells and protective immunity to tuberculosis","volume":"783","author":"Behar","year":"2013","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.cca.2023.117559_b0065","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00180","article-title":"Functional signatures of human CD4 and CD8 T cell responses to Mycobacterium tuberculosis","volume":"5","author":"Prezzemolo","year":"2014","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.cca.2023.117559_b0070","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1002\/eji.201243262","article-title":"Mycobacterium tuberculosis-specific CD8+ T cells are functionally and phenotypically different between latent infection and active disease","volume":"43","author":"Rozot","year":"2013","journal-title":"Eur. J. Immunol."},{"issue":"9","key":"10.1016\/j.cca.2023.117559_b0075","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01950-19","article-title":"Fourth-generation QuantiFERON-TB gold plus: What is the evidence?","volume":"58","author":"Shafeque","year":"2020","journal-title":"J. Clin. Microbiol."},{"issue":"12","key":"10.1016\/j.cca.2023.117559_b0080","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1016\/j.jiac.2021.08.016","article-title":"Clinical evaluation of QuantiFERON-TB Gold Plus directly compared with QuantiFERON-TB Gold In-Tube and T-Spot.TB for active pulmonary tuberculosis in the elderly","volume":"27","author":"Fukushima","year":"2021","journal-title":"J. Infect. Chemother."},{"issue":"6","key":"10.1016\/j.cca.2023.117559_b0085","doi-asserted-by":"crossref","first-page":"690","DOI":"10.5588\/ijtld.16.0764","article-title":"The sensitivity of the QuantiFERON\u00ae-TB Gold Plus assay in Zambian adults with active tuberculosis","volume":"21","author":"Telisinghe","year":"2017","journal-title":"Int. J. Tuberc. Lung Dis."},{"issue":"5","key":"10.1016\/j.cca.2023.117559_b0090","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1183\/13993003.00510-2016","article-title":"First evaluation of QuantiFERON-TB Gold Plus performance in contact screening","volume":"48","author":"Barcellini","year":"2016","journal-title":"Eur. Respir. J."},{"issue":"4","key":"10.1016\/j.cca.2023.117559_b0095","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jinf.2013.06.005","article-title":"Factors influencing discordant results of the QuantiFERON-TB Gold In-tube test in patients with active TB","volume":"67","author":"Jeon","year":"2013","journal-title":"J. Infect."},{"issue":"5","key":"10.1016\/j.cca.2023.117559_b0100","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1183\/13993003.00403-2015","article-title":"Discordance between the QuantiFERON-TB Gold In-Tube and Tuberculin Skin Test: need for a further step?","volume":"46","author":"Spinicci","year":"2015","journal-title":"Eur. Respir. J."},{"issue":"8","key":"10.1016\/j.cca.2023.117559_b0105","doi-asserted-by":"crossref","first-page":"ofy184","DOI":"10.1093\/ofid\/ofy184","article-title":"Risk factors for indeterminate outcome on interferon gamma release assay in non-US-born persons screened for latent tuberculosis infection","volume":"5","author":"Sharninghausen","year":"2018","journal-title":"Open Forum Infect Dis"},{"issue":"11","key":"10.1016\/j.cca.2023.117559_b0110","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1093\/cid\/ciaa519","article-title":"Predictors of discordant tuberculin skin test and QuantiFERON-TB gold in-tube results in Eastern China: A population-based","volume":"72","author":"Lu","year":"2021","journal-title":"Cohort Study. Clin Infect Dis."},{"issue":"3","key":"10.1016\/j.cca.2023.117559_b0115","doi-asserted-by":"crossref","first-page":"e3227","DOI":"10.1002\/dmrr.3227","article-title":"Undiagnosed diabetes mellitus and tuberculosis infection: A population-based, observational study from eastern China","volume":"36","author":"Liu","year":"2020","journal-title":"Diabetes Metab. Res. Rev."},{"issue":"8","key":"10.1016\/j.cca.2023.117559_b0120","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00427-18","article-title":"QuantiFERON-TB gold plus is a more sensitive screening tool than QuantiFERON-TB gold in-tube for latent tuberculosis infection among older adults in long-term care facilities","volume":"56","author":"Chien","year":"2018","journal-title":"J. Clin. Microbiol."},{"issue":"3","key":"10.1016\/j.cca.2023.117559_b0125","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S1473-3099(15)70040-X","article-title":"How frequent is latent tuberculosis infection in China?","volume":"15","author":"Zellweger","year":"2015","journal-title":"Lancet Infect. Dis."},{"issue":"5","key":"10.1016\/j.cca.2023.117559_b0130","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1183\/09031936.00122109","article-title":"Indeterminate results of a tuberculosis-specific interferon-gamma release assay in immunocompromised patients","volume":"35","author":"Lange","year":"2010","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.cca.2023.117559_b0135","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1164\/rccm.201203-0430OC","article-title":"Test variability of the QuantiFERON-TB gold in-tube assay in clinical practice","volume":"187","author":"Metcalfe","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.cca.2023.117559_b0140","doi-asserted-by":"crossref","first-page":"1701267","DOI":"10.1183\/13993003.01267-2017","article-title":"Frequency and significance of indeterminate and borderline Quantiferon Gold TB IGRA results","volume":"50","author":"Brown","year":"2017","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.cca.2023.117559_b0145","first-page":"33","article-title":"Guidelines for using QuantiFERON TB Gold in-tube","volume":"88","year":"2013","journal-title":"Kekkaku"},{"key":"10.1016\/j.cca.2023.117559_b0150","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.tube.2018.06.002","article-title":"Borderline QuantiFERON results and the distinction between specific responses and test variability","volume":"111","author":"Uzorka","year":"2018","journal-title":"Tuberculosis (Edinb.)"},{"issue":"5","key":"10.1016\/j.cca.2023.117559_b0155","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1164\/rccm.201704-0817OC","article-title":"Optimization and interpretation of serial QuantiFERON testing to measure acquisition of mycobacterium tuberculosis infection","volume":"196","author":"Nemes","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"6","key":"10.1016\/j.cca.2023.117559_b0160","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1128\/JCM.02403-07","article-title":"Comparison of sensitivities of two commercial gamma interferon release assays for pulmonary tuberculosis","volume":"46","author":"Chee","year":"2008","journal-title":"J. Clin. Microbiol."},{"issue":"1","key":"10.1016\/j.cca.2023.117559_b0165","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-24285-3","article-title":"Prospective comparison of QFT-GIT and T-SPOT.TB assays for diagnosis of active tuberculosis","volume":"8","author":"Du","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cca.2023.117559_b0170","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.cca.2022.05.028","article-title":"Indeterminate results of QuantiFERON-TB Gold in-tube due to high nil concentration and methodological exploration and improvement","volume":"533","author":"Peng","year":"2022","journal-title":"Clin. Chim. Acta"},{"issue":"10","key":"10.1016\/j.cca.2023.117559_b0175","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1136\/thoraxjnl-2016-209397","article-title":"Corticosteroids and infliximab impair the performance of interferon-\u03b3 release assays used for diagnosis of latent tuberculosis","volume":"72","author":"Edwards","year":"2017","journal-title":"Thorax"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898123003613?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898123003613?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:10:19Z","timestamp":1757862619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898123003613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":35,"alternative-id":["S0009898123003613"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2023.117559","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploration and improvement of QuantiFERON-TB assay in patients with indeterminate results in clinical practice: A head-to-head study","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2023.117559","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117559"}}